Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: Neurofeedback of Amygdala Activity for Post-traumatic Stress Disorder [NA]

View source ↗

Summary

Clinical trial update on neurofeedback targeting amygdala activity for post-traumatic stress disorder; study status terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Post-Traumatic Stress Disorder | NA | Status: TERMINATED | Results posted: 2023-10-18